Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|September 6, 2017
[Over-expressed HER2 enhances proliferation, migration and invasion of melanoma B16 cells]Wenjiao Xia, Chengui Lu, Xiaoyin Wang, et al.
Journal of Biotechnology|August 23, 2018
VEGF165b mutant with a prolonged half-life and enhanced anti-tumor potency in a mouse modelHuiyong Zhang, Enchao Jia, Wenjiao Xia, et al.
Phytotherapy Research : PTR|February 11, 2025
Enhancing NK Cell Antitumor Activity With Natural Compounds: Research Advances and Molecular MechanismsYu Wu, Mingxiao Yin, Wenjiao Xia, et al.
Molecular Immunology|October 17, 2020
VEGF165b augments NK92 cytolytic activity against human K562 leukemia cells by upregulating the levels of perforin and granzyme B via the VEGR1-PLC pathwayXiaoyin Wang, Chen Liang, Wenjiao Xia, et al.
Vaccine|March 7, 2019
Utilizing VEGF165b mutant as an effective immunization adjunct to augment antitumor immune responseHuiyong Zhang, Enchao Jia, Wenjiao Xia, et al.
Oncoimmunology|November 8, 2021
Metformin promotes anticancer activity of NK cells in a p38 MAPK dependent mannerWenjiao Xia, Xin Qi, Mingfeng Li, et al.
Molecular Immunology|May 1, 2020
VEGF165b and its mutant demonstrate immunomodulatory, not merely anti-angiogenic functions, in tumor-bearing miceHuiyong Zhang, Wenjiao Xia, Chen Liang, et al.
International Journal of Biological Sciences|January 9, 2025
The positive feedback loop between SP1 and MAP2K2 significantly drives resistance to VEGFR inhibitors in clear cell renal cell carcinomaZhinan Xia, Zitong Yang, Yu Dong, et al.
International Journal of Molecular Sciences|April 13, 2023
Engineering a HER2-CAR-NK Cell Secreting Soluble Programmed Cell Death Protein with Superior Antitumor EfficacyWenjiao Xia, Jiaxin Chen, Wenqing Hou, et al.
Cancers|May 13, 2026
An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in ccRCC and Identifies UCN-Mediated Immune Evasion as a Therapeutic Vulnerability: Evidence from In Vitro and In Vivo StudiesZhinan Xia, Yu Dong, Xin Zhang, et al.
Pageof 2